Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06282939 · ClinicalTrials.gov registry record
Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry
A clinical trial of Intracranial Aneurysm, sponsored by HCA Healthcare Research Institute.
- Recruiting
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT06282939: Recruiting study of Intracranial Aneurysm, sponsored by HCA Healthcare Research Institute.
NCT06282939 is a study of Intracranial Aneurysm that is actively recruiting participants, run by HCA Healthcare Research Institute. The registered enrollment target is 600 participants, below the 9,153-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06282939, a study of Intracranial Aneurysm, is actively recruiting participants, sponsored by HCA Healthcare Research Institute.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, open-label, consecutive enrollment, multi-center, U.S. registry of patients with intracranial aneurysms who are treated with the Optima Coil System. The primary objective of this registry is to evaluate the safety and effectiveness of the OptimaTM Coil System, including the OptiMAX Coils, in the real-world treatment of intracranial aneurysms. Imaging will be analyzed by a designated core neuroimaging lab to assess procedural success and aneurysm occlusion rates. Intent to treat population total: 700 patients 600 patients, up to 100 screen failures.
Primary Outcome
Rated by a designated core lab without retreatment as confirmed by core lab adjudication.
Conditions Studied
Interventions
- DEVICE OPTIMA and OPTIMAX Coils manufactured by Balt USA
Study Locations (1)
Texas
- Med City Plano - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2027-12-01 |
What NCT06282939 shows while recruiting
NCT06282939 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 9,153-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which OPTIMA and OPTIMAX Coils manufactured by Balt USA is the first listed.
NCT06282939 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06282939 about?
NCT06282939 is a clinical study titled "Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry". This is a prospective, open-label, consecutive enrollment, multi-center, U.S. registry of patients with intracranial aneurysms who are treated with the Optima Coil System. The primary objective of this registry is to evaluate the safety and effectiveness of the OptimaTM Coil System, including the O...
What is the current status of trial NCT06282939?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2023-11-01. Estimated completion is 2027-12-01.
What conditions does trial NCT06282939 study?
This clinical trial studies the following conditions: Intracranial Aneurysm.
What interventions are being tested in trial NCT06282939?
The interventions under investigation include: OPTIMA and OPTIMAX Coils manufactured by Balt USA (DEVICE).
Who is sponsoring clinical trial NCT06282939?
This trial is sponsored by HCA Healthcare Research Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06282939 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06282939's enrollment target sits among peer trials
600 5th of 14 higher than 10 of 14 other Intracranial Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracranial Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Product Surveillance Registry
RECRUITING
-
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
RECRUITING
-
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
RECRUITING
-
@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms
RECRUITING
-
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
RECRUITING · NA
-
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI